Allogeneic NK cells generated from cord blood as universal treatment for cervical cancer enabled by HLA independent killing mechanisms.

John Veluchamy,A. Marijne Heeren,Jan Spanholtz,Jaap van Eendenburg,Daniëlle A.M. Heideman,Henk M.W. Verheul,Gemma G. Kenter,Hans J. van der Vliet,Ekaterina S. Jordanova,Tanja D. de Gruijl

Allogeneic NK cells generated from cord blood as universal treatment for cervical cancer enabled by HLA independent killing mechanisms.

2016

John Veluchamy
A. Marijne Heeren
Jan Spanholtz
Jaap van Eendenburg
Daniëlle A.M. Heideman
Henk M.W. Verheul
Gemma G. Kenter
Hans J. van der Vliet
Ekaterina S. Jordanova
Tanja D. de Gruijl

e14526Background: Cetuximab monotherapy is not effective in epidermal growth factor receptor (EGFR) positive cervical cancer patients. NK cells synergize with cetuximab through antibody dependent c...

Keywords:

Pathology
Immunology
Cervical cancer
Cord blood
Medicine
Human leukocyte antigen
Epidermal growth factor receptor
Antibody
Cetuximab
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations